Immunohistochemistry of Thymic Epithelial Tumors as a Tool in Translational Research

Mirella Marino, Mauro Piantelli

Research output: Contribution to journalArticlepeer-review


Due to their heterogeneity and infrequency, thymic epithelial cell tumors (TET) represent a diagnostic as well as a therapeutic problem. In the early stage of disease TET are usually cured by performing radical resections, whereas in advanced stages of disease they are usually radically unresectable from the beginning, and often show multiple relapses and/or intra- or extrathoracic metastases. Trained pathologists are required in TET diagnostics; awareness of the complexity of the mediastinum and of the differential diagnostic possibilities is mandatory. Immunohistochemical (IHC) studies play a fundamental role in oncologic surgical pathology. Among the many uses of IHC in cancer research, studies on a possible association between biomarker expression and treatment outcomes dominate the clinical translational research applications. This article reports on and discusses the role of IHC in diagnostic and translational research of TET.

Original languageEnglish
Pages (from-to)33-46
Number of pages14
JournalThoracic Surgery Clinics
Issue number1
Publication statusPublished - Feb 2011


  • Biomarkers
  • Immunohistochemistry
  • Thymoma
  • Vascular endothelial growth factor
  • Vascular endothelial growth factor receptor

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine
  • Surgery


Dive into the research topics of 'Immunohistochemistry of Thymic Epithelial Tumors as a Tool in Translational Research'. Together they form a unique fingerprint.

Cite this